UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

NCT07001254 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia

Interventions

DRUG: Romiplostim
DRUG: Immunosuppressive therapy (IST)

Sponsor

Anjali Sharathkumar

Collaborators

[object Object]
[object Object]